Publication | Closed Access

Nab-paclitaxel plus gemcitabine versus FOLFIRINOX as the first-line chemotherapy for patients with metastatic pancreatic cancer: retrospective analysis

OncologyPancreatic CancerGastrointestinal OncologyMedicineGemcitabine Versus FolfirinoxRetrospective AnalysisPharmacotherapyMetastatic Pancreatic CancerCancer TreatmentPharmacologyMolecular Oncology